Viewing Study NCT06768905


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2025-12-31 @ 1:59 AM
Study NCT ID: NCT06768905
Status: RECRUITING
Last Update Posted: 2025-05-01
First Post: 2025-01-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of IOMAB-ACT Followed by CAR-T Cell Therapy for Patients Relapsed or Refractory (Diffuse Large B-cell Lymphoma
Sponsor: University of Texas Southwestern Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: STU-2024-1091; SCCC-03424
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View